EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas

Kevin A Huynh, James MacFarlane, Waiel A Bashari, Daniel Gillett, Mark Gurnell

Endocrinology and Metabolism Clinics of North America · 2025-12 · 54 (4) · 549-562

DOI: 10.1016/j.ecl.2025.08.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2025-12. Verfasst von Kevin A Huynh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ…. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Adenoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Institute for Health and Care Research, NIHR Cambridge Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate tumor localization is essential for optimal treatment planning in patients with pituitary adenomas. Recent advances in MRI allow improved detection of sites of de novo and residual disease and can also provide improved visualization of adjacent critical structures such as those contained within the cavernous sinus. Molecular imaging (PET) is increasingly used either to confirm or exclude functional activity in lesions identified on MRI or to reveal previously unsuspected tumor foci. As more centers adopt these and other emerging techniques (eg, photon-counting detector computed tomography), an increasing number of patients are likely to benefit from more precise, personalized management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsAdenomaHumansMagnetic Resonance ImagingPositron-Emission Tomography

Stichwörter der Autor:innen

Computed tomography (CT)Magnetic resonance imaging (MRI)Molecular/functional imagingPituitary adenomaPositron emission tomography (PET)

Autor:innen und Institutionen

  • Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge & Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ; National Institute for Health Research Cambridge Biomedical Research…

Förderung

  • National Institute for Health and Care Research
  • NIHR Cambridge Biomedical Research Centre

Zitieren

APA

Huynh, K. A., MacFarlane, J., Bashari, W. A., Gillett, D., & Gurnell, M. (2025). Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas. Endocrinology and Metabolism Clinics of North America, 54(4), 549-562. https://doi.org/10.1016/j.ecl.2025.08.001

Vancouver

Huynh KA, MacFarlane J, Bashari WA, Gillett D, Gurnell M. Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas. Endocrinology and Metabolism Clinics of North America. 2025;54(4):549-562. doi:10.1016/j.ecl.2025.08.001

BibTeX
@article{Huynh2025,
  author = {Huynh, Kevin A and MacFarlane, James and Bashari, Waiel A and Gillett, Daniel and Gurnell, Mark},
  title = {Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2025},
  volume = {54},
  number = {4},
  pages = {549--562},
  doi = {10.1016/j.ecl.2025.08.001}
}
Kostenlos starten →